Focus Partners Wealth Invests $551,000 in Jazz Pharmaceuticals plc (NASDAQ:JAZZ)
Focus Partners Wealth bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 4,469 shares of the specialty pharmaceutical company’s stock, valued at approximately $551,000. A number of other hedge funds also recently modified their holdings of the stock. Bessemer Group […]
Focus Partners Wealth bought a new position in shares of Jazz Pharmaceuticals plc (NASDAQ:JAZZ – Free Report) in the fourth quarter, HoldingsChannel reports. The institutional investor bought 4,469 shares of the specialty pharmaceutical company’s stock, valued at approximately $551,000. A number of other hedge funds also recently modified their holdings of the stock. Bessemer Group […]
